Kansas City, Kan- Carrie Mooneyham's breast cancer journey, highlights her proactive approach to health and the critical difference in care she received at the University of Kansas Cancer Center compared to her initial diagnosis.
Dr. Anne O'Dea, Mooneyham's oncologist, explained the targeted treatments for HER2-positive breast cancer and emphasized the importance of nurse navigators in patient care. Mooneyham's positive attitude and community support were also highlighted.
Note: this is an encore presentation due to weather.
Carrie Mooneyham, breast cancer survivor
- Carrie's initial experience, at another hospital, was negative, with a lack of empathy and a vague plan for treatment.
- Carrie sought a second opinion at the University of Kansas Cancer Center, where she met Dr. Anne O’Dea, who provided hope and a clear treatment plan.
- Carrie's treatment includes chemotherapy, a mastectomy, and cancer surveillance, but she remains positive and focused on her family and faith.
Dr. Anne O’Dea, Medical Oncologist, University of Kansas Cancer Center Breast Cancer Care Hospital Kansas City | The University of Kansas Center Center
- Dr. O'Dea explains the specifics of Carrie's diagnosis, including the importance of targeted treatments for HER2-positive breast cancer.
- The segment emphasizes the advancements in breast cancer treatment and the hope for a cure, with Dr. O'Dea expressing optimism for Carrie's recovery.